Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404]

IF 5.5 2区医学 Q1 HEMATOLOGY

Critical reviews in oncology/hematology Pub Date : 2024-12-01 DOI:10.1016/j.critrevonc.2024.104542

M. Sirico , F. Jacobs , C. Molinelli , Guilherme Nader-Marta , V. Debien , H.Faith Dewhurst , M. Pallesch , F. Merloni , C. Gianni , U. De Giorgi , Evandro de Azambuja

引用次数: 0

查看原文本刊更多论文

HER-2 阴性乳腺癌中 PI3K/AKT 通路的复杂性：Biomarkers and beyond" [Crit. Rev. Oncol./Hematol.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Critical reviews in oncology/hematology 医学-血液学

CiteScore

11.00

自引率

3.20%

发文量

213

审稿时长

55 days

期刊介绍： Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.